Dr. Michael Birrer will be focused on developing new types of drug models and molecular approaches to help create alternative forms of treatment for multiple types of ovarian cancers. While his primary focus will be on of ovarian cancer, he hopes his research, and ongoing clinical trials will also help in the development of new treatments for multiple types of cancers studied here at the Winthrop P. Rockefeller Cancer Institute. Dr. Birrer has also been chosen to lead the UAMS goal of achieving the National Cancer Institute designation, and he has assembled a top-notch team of doctors, oncologists, surgeons, and researchers to help him on this journey.